AGM Statement

Advanced Medical Solutions Grp PLC
24 May 2005


For immediate release                                   24 May 2005

                    
                          Advanced Medical Solutions Group plc
                               ('AMS' or 'the Company')

                             Annual General Meeting


Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global
woundcare technology company, today held its Annual General Meeting at which all
of the resolutions put to shareholders were duly passed.



Don Evans, AMS's Chief Executive, gave a presentation, a copy of which will be
available on the Company's website, www.admedsol.com, later today.



                                     -ENDS-


For further information, please contact:


Advanced Medical Solutions Group plc                   Tel : [phone]
Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com


Buchanan Communications                                Tel: [phone]
Mark Court, Mary-Jane Johnson


Notes to Editors:



Advanced Medical Solutions is a leading company in the development and
manufacture of products for the $15 billion global woundcare market.



Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is
focused on the design, development and manufacture of innovative and
technologically advanced products for woundcare and other medical applications.



In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS's resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.



The acquisition of MedLogic in 2002 has brought AMS products and technology in
cyanoacrylate based tissue adhesives that offer benefits over sutures and
staples for closing wounds sold direct to hospitals or through distributors.



AMS's technology and products currently serve the majority of the key global
markets with strategic partners including 3M, Novartis, Johnson & Johnson,
Molnlycke Healthcare, Smith + Nephew and Cardinal Health.






                      This information is provided by RNS
            The company news service from the London Stock Exchange